Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Several possible studies

Story checked

Revolutionizing CRC screening: BGI genomics in latin america (opens in a new tab)

news-medical.net · 2026-10-22

Short answerEvidenceSource

Short answer

Several possible studies

Study not confirmed.

Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.

22 candidate papersExplore the search results

These papers were considered as possible sources, but none could be confirmed as the study behind this story.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Multiple potential source studies identified.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

View article claims
3

Search result

Several studies could fit.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

Source paper

Source layer

The 3 papers the story cites

Source study separated from background citations.

The research anchor for the report.

The literature search

22 candidate papers

Studies identified during the search

These papers appeared in the search for the story’s source. None was confirmed as a direct match. Inclusion here does not mean a paper supports or contradicts the story, or that its full text was reviewed.

Show 18 more search results
Then inspect each claim

Evidence layer

Claim by claim

The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.

Claim 1 of 5Not checkedColorectal cancer is described as one of the most urgent yet addressable oncology challenges in Latin America, with diagnostic bottlenecks and delayed treatment limiting care.View evidenceHide evidence

As statedmedian interval to definitive treatment stretches to 7 months

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 2 of 5Not checkedThe article says BGI Genomics' COLOTECT demonstrates how non-invasive epigenetic methylation screening can intercept disease early and bridge the diagnostic gap before curable windows close.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 3 of 5Not checkedIt states that COLOTECT targets hypermethylation across validated biomarkers such as SDC2, ADHFE1, and PPP2R5C to detect cellular alterations in precancerous adenomas before visible bleeding triggers FIT.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 4 of 5Not checkedThe article says stool collection is painless and non-invasive and does not require bowel preparation, fasting, or sedation, which it says lowers barriers to screening in underserved areas.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 5 of 5Not checkedIt reports that real-world data show approximately 80% of people with positive results who underwent colonoscopy had confirmed colorectal abnormalities.View evidenceHide evidence

As statedapproximately 80%

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Finally, the search trail

Method layer

Study not confirmed.

The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.

Search results

Candidate papers, not confirmed sources.

PubMed, Europe PMC, Crossref · 17 candidate papers

Candidate

Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer

2017 · Crossref

Source (opens in a new tab)

Explore all search results